Altamira Therapeutics Ltd. — SC 13G/A Filings
13 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Altamira Therapeutics Ltd. (CYTOF), sorted by most recent first. Each row links to the full filing on EdgarLookup. Altamira Therapeutics Ltd. has filed 13 SC 13G/A documents with the SEC since 2014. To view all SEC filings by Altamira Therapeutics Ltd., see the full filings list.
All
15-12G
15F-12B
20-F
20-F/A
25-NSE
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-A12B/A
8-K12G3
CERT
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-4
F-4/A
FWP
NT 20-F
POS AM
POS EX
RW
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | AMENDMENT TO FORM SC 13G | 0001387131-21-002303 | Feb 12, 2021 | — |
| SC 13G/A | AMENDMENT TO FORM SC 13G | 0001387131-20-001844 | Feb 14, 2020 | — |
| SC 13G/A | SC 13G/A | 0001019056-19-000149 | Feb 15, 2019 | — |
| SC 13G/A | SCHEDULE 13G/A (AMENDMENT NO. 3) | 0001193125-18-045560 | Feb 14, 2018 | — |
| SC 13G/A | AMENDMENT NO. 3 | 0000947871-18-000122 | Feb 12, 2018 | — |
| SC 13G/A | EMPERY ASSET MANAGEMENT, LP | 0000902664-18-000218 | Jan 16, 2018 | — |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0000947871-17-000125 | Feb 14, 2017 | — |
| SC 13G/A | — | 0000315066-17-001463 | Feb 14, 2017 | — |
| SC 13G/A | — | 0000814133-16-000097 | Sep 9, 2016 | — |
| SC 13G/A | SC 13G/A | 0001193125-16-648114 | Jul 14, 2016 | — |
| SC 13G/A | LIVE SUBMISSION | 0001540796-16-000020 | Feb 12, 2016 | — |
| SC 13G/A | SC 13G/A | 0001193125-16-461972 | Feb 12, 2016 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0000947871-16-000961 | Feb 12, 2016 | — |